Skip to main content


Hepatology International

Hepatology International OnlineFirst articles

03.08.2021 | Original Article Open Access

The global trends and regional differences in incidence and mortality of hepatitis A from 1990 to 2019 and implications for its prevention

Hepatitis A caused by hepatitis A virus (HAV) is the most common form of acute viral hepatitis globally [ 1 ]. HAV first identified by Feinstone and colleagues, is a member of the Hepatovirus genus of the family Picornaviridae [ 2 , 3 ]. HAV is …

02.08.2021 | Original Article

Iodized oil computed tomography versus ultrasound-guided radiofrequency ablation for early hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths in men and the sixth leading cause in women worldwide. The Barcelona Clinic Liver Cancer (BCLC) staging system stratifies patients with HCC into very early, early …

31.07.2021 | Original Article

Targeted inhibition of FGF19/FGFR cascade improves antitumor immunity and response rate in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is amongst the five most common cancers globally, with nearly 1 million new cases diagnosed annually [ 1 ]. Currently, sorafenib, lenvatinib, and combination of atezolizumab and bevacizumab are approved by the FDA as …

28.07.2021 | Original Article

Hepatopulmonary syndrome is related to the development of acute-on-chronic liver failure and poor prognosis in cirrhotic patients

Hepatopulmonary syndrome (HPS) is characterized as a defect in arterial oxygenation caused by pulmonary vascular dilatation in the setting of chronic liver disease [ 1 – 6 ]. It is defined by positive echocardiography findings and a more than 15 …

27.07.2021 | Original Article

Alterations of gut microbiome and metabolite profiles in choledocholithiasis concurrent with cholangitis

Choledocholithiasis concurrent with cholangitis (CC), known as the sudden onset of obstruction and inflammation in the common bile duct owing to extrahepatic bile duct stones, is characterized by severe abdominal pain, obstructive jaundice and …

Aktuelle Ausgaben

Über diese Zeitschrift

Hepatology International is a peer-reviewed journal featuring articles written by clinicians, clinical researchers and basic scientists is dedicated to research and patient care issues in hepatology. This journal focuses mainly on new and emerging diagnostic and treatment options, protocols and molecular and cellular basis of disease pathogenesis, new technologies, in liver and biliary sciences.

Hepatology International publishes original research articles related to clinical care and basic research; review articles; consensus guidelines for diagnosis and treatment; invited editorials, and controversies in contemporary issues. The journal does not publish case reports..

Hepatology International requests that all authors comply to Springer’s ethical policies. These ethical statements should be clearly indicated on all articles for all 3 ethics statements and for all authors mentioned by name. These statements should be placed at the end of each article just before the Reference section.

To visit our ethics statements please visit the following links:

Conflict of Interest and Ethical Standards:

Informed Consent:

Statement of Human and Animal Rights:

Hepatology International is the official journal of the Asian Pacific Association for the Study of the Liver (APASL).

Now indexed by ISI

Weitere Informationen

Neu im Fachgebiet Innere Medizin

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.

© Springer Medizin